Overview Financials News + Filings Key Docs Charts Holdings Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Quarterly results Appointed director
|
Bellerophon Therapeutics, Inc. (BLPH)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
04/03/2023 |
3
| Kim Bobae (VP Reg. Affairs & Quality) has filed a Form 3 on Bellerophon Therapeutics, Inc. |
10/08/2021 |
3
| Laccona Nicholas (Controller, (PFO & PAO)) has filed a Form 3 on Bellerophon Therapeutics, Inc. |
09/11/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
03/27/2019 |
3
| Teufel Crispin (Director) has filed a Form 3 on Bellerophon Therapeutics, Inc. |
08/16/2018 |
3
| VENROCK ASSOCIATES IV L P (10% Owner) has filed a Form 3 on Bellerophon Therapeutics, Inc. |
08/16/2018 |
3
| VENROCK ASSOCIATES IV L P (10% Owner) has filed a Form 3 on Bellerophon Therapeutics, Inc. |
04/13/2018 |
3
| Puissance Cross-Border Opportunities III LLC (10% Owner) has filed a Form 3 on Bellerophon Therapeutics, Inc. |
03/30/2018 |
3
| BENNETT MATTHEW (Director) has filed a Form 3 on Bellerophon Therapeutics, Inc. |
01/17/2018 |
3
| Korner Assaf (CFO) has filed a Form 3 on Bellerophon Therapeutics, Inc. |
12/04/2017 |
3
| Wang Theodore T (10% Owner) has filed a Form 3 on Bellerophon Therapeutics, Inc. |
03/16/2017 |
3
| Schoeps Megan (Principal Financial Officer) has filed a Form 3 on Bellerophon Therapeutics, Inc. |
05/04/2016 |
3
| Shah Parag Suresh (VP Proj Mgmt & Distribution) has filed a Form 3 on Bellerophon Therapeutics, Inc. |
03/01/2016 |
3
| Tenenbaum Fabian (CFO & Chief Business Officer) has filed a Form 3 on Bellerophon Therapeutics, Inc. |
|
|